(111 days)
Not Found
No
The document describes a quality control serum for laboratory testing and does not mention any AI or ML components in its description, intended use, or performance studies.
No
This device is a quality control serum used to monitor the precision of laboratory testing procedures, not to treat a condition.
No
This device is a quality control serum used to monitor the precision of laboratory testing procedures, not to diagnose a condition in a patient.
No
The device description clearly states it is a human serum based product provided in lyophilized form in glass bottles, indicating it is a physical reagent, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's for "monitoring the precision of laboratory testing procedures for the following analytes." This indicates it's used in a laboratory setting to evaluate the performance of diagnostic tests.
- Device Description: The description details a "human serum based product containing constituents of purified biochemicals... therapeutic drugs, preservatives and stabilizers." This is a typical composition for a quality control material used in in vitro diagnostic testing.
- Function: The device acts as an "assayed quality control serum." Quality control materials are essential components of IVD testing to ensure the accuracy and reliability of results.
- Context: The description mentions use "on instruments listed in the expected values chart," further reinforcing its role in laboratory testing procedures.
- Predicate Device: The mention of a predicate device (K103364; Mission CliniCheck Assayed Chemistry) which is also an IVD, strongly suggests that this device falls under the same category.
Therefore, based on its intended use, description, and function within a laboratory setting for monitoring diagnostic tests, the Mission CliniCheck Controls is an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Mission CliniCheck Controls is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the following analytes, Acetaminophen, Acid Phosphatase (Total), Alanine Aminotransferase (ALT/GPT), Albumin, Alkaline Phosphatase (ALP), Alpha-1 Anti-Trypsin, Alpha Fetoprotein, Alpha Hydroxybutyrate Dehydrogenase (α-HBDH), Amylase, Apolipoprotein A-1 (APO-A1), Aspartate Aminotransferase (AST/GOT), Bilirubin (Direct), Bilirubin (Total), C3 Complement, C4 Complement, Calcium, Carbon Dioxide (CO2), Carcinoembryonic Antigen (CEA), Ceruloplasmin, Chloride, Cholesterol (Total), HDL- Cholesterol, LDL-Cholesterol, Cholinesterase, Creatine Kinase (CK), Creatinine, Digoxin, Gamma Glutamyltransferase (GGT), Glucose, Haptoglobin, Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Iron, Iron-Binding Capacity, Total (TIBC), Iron Binding Capacity, Unsaturated (UIBC), Lactate (Lactic acid), Lactate Dehydrogenase (LDH), Lipase, Lithium, Magnesium, Phosphorus, Potassium, Protein-Total, Salicylate, Sodium, T3 Free, T3 Total, T4 Free, T4 Total, Thyroid Stimulating Hormone (TSH), Transferrin, Triglycerides, Urea, Urea Nitrogen, and Uric Acid on instruments listed in the expected values chart.
Product codes
JJY
Device Description
Mission CliniCheck Assayed Chemistry Control is a human serum based product containing constituents of purified biochemicals (tissue extracts of human and animal origin), chemicals, therapeutic drugs, preservatives and stabilizers. Two levels of Control are provided in a lyophilized form. Each level is packaged into a glass amber bottle containing 5mL of product. The product is packaged in single level boxes (12 x 5mL) or multiple level boxes (6 x 2 x 5mL) and stored at 2 - 8°C.
All human source material was tested and found negative by FDA approved methods for HBsAg, HCV, and HIV-1/2.
Value Assignment: Mission CliniCheck Assayed Chemistry Control value assignment is lot specific. Lot to lot variation is determined by testing new lot vs. previous lot normalized to either a serum standard made with corresponding analyte NIST or Original Equipment Manufacturer (OEM). The target values are obtained by testing 16 replicates, 4 replicates each over a period of 4 days. The average of these 16 data points is the mean. The range is then determined by multiplying the mean by ± 20%, creating the upper and lower range. All testing is performed alongside (OEM) Original Equipment Manufacturer material to verify values before accepting new ranges.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Tests were conducted to determine stability. Accelerated (high temperature) stress test was done and results support a 2 year shelf life when the controls are stored at 2-8°C. Testing showed that reconstituted Mission CliniCheck Assayed Chemistry Controls are stable for up to 20 days at -20°C. Once thawed, the controls cannot be refrozen and must be discarded. Values are also stable for 7 days when stored at 2-8℃ with the following exception: Acid Phosphatase will be stable for 3 days, AST for 1 day, CK, LDH, T4 free and TSH for 6 days when stored tightly capped at 2-8℃.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
·5. 510(k) Summary
:
:
:
..
| 510(k) Number: | K124009 | APR 1 7 2013 |
|---|---|---|
| Applicant: | Diamond Diagnostics, Inc. | |
| 333 Fiske Street | ||
| Holliston, MA 01746 | ||
| Contact Person: | Kathy Cruz | |
| Quality Assurance Manager | ||
| Phone: (508) 429-0450 ext. 351 | ||
| Fax: (508) 429-0452 | ||
| Date Prepared: | April 17, 2013 | |
| Classification Name: | Assayed Quality Control Material | |
| Trade Name: | Mission CliniCheck Assayed Chemistry Control | |
| Device Classification: 21 CFR 862.1660 | ||
| Device Class: | Class I (Reserved) | |
| Classification Panel: | Clinical Chemistry | |
| Product Code: | JJY | |
| Intended Use: | Mission CliniCheck Controls is intended for use as an assayed quality control serum | |
| to monitor the precision of laboratory testing procedures for the following analytes, | ||
| Acetaminophen, Acid Phosphatase (Total), Alanine Aminotransferase (ALT/GPT), | ||
| Albumin, Alkaline Phosphatase (ALP), Alpha-1 Anti-Trypsin, Alpha Fetoprotein, | ||
| Alpha Hydroxybutyrate Dehydrogenase (α-HBDH), Amylase, Apolipoprotein A-1 | ||
| (APO-A1), Aspartate Aminotransferase (AST/GOT), Bilirubin (Direct), Bilirubin | ||
| (Total), C3 Complement, C4 Complement, Calcium, Carbon Dioxide (CO2), | ||
| Carcinoembryonic Antigen (CEA), Ceruloplasmin, Chloride, Cholesterol (Total), HDL- | ||
| Cholesterol, LDL-Cholesterol, Cholinesterase, Creatine Kinase (CK), Creatinine, | ||
| Digoxin, Gamma Glutamyltransferase (GGT), Glucose, Haptoglobin, Immunoglobulin | ||
| A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Iron, Iron-Binding | ||
| Capacity, Total (TIBC), Iron Binding Capacity, Unsaturated (UIBC), Lactate (Lactic | ||
| acid), Lactate Dehydrogenase (LDH), Lipase, Lithium, Magnesium, Phosphorus, | ||
| Potassium, Protein-Total, Salicylate, Sodium, T3 Free, T3 Total, T4 Free, T4 Total, | ||
| Thyroid Stimulating Hormone (TSH), Transferrin, Triglycerides, Urea, Urea Nitrogen, | ||
| and Uric Acid on instruments listed in the expected values chart. |
:
な
:
.
.
.
1
Device Description: Mission CliniCheck Assayed Chemistry Control is a human serum based product containing constituents of purified biochemicals (tissue extracts of human and animal origin), chemicals, therapeutic drugs, preservatives and stabilizers. Two levels of Control are provided in a lyophilized form. Each level is packaged into a glass amber bottle containing 5mL of product. The product is packaged in single level boxes (12 x 5mL) or multiple level boxes (6 x 2 x 5mL) and stored at 2 - 8°C.
All human source material was tested and found negative by FDA approved methods for HBsAg, HCV, and HIV-1/2.
Value Assignment: Mission CliniCheck Assayed Chemistry Control value assignment is lot specific. Lot to lot variation is determined by testing new lot vs. previous lot normalized to either a serum standard made with corresponding analyte NIST or Original Equipment Manufacturer (OEM). The target values are obtained by testing 16 replicates, 4 replicates each over a period of 4 days. The average of these 16 data points is the mean. The range is then determined by multiplying the mean by ± 20%, creating the upper and lower range. All testing is performed alongside (OEM) Original Equipment Manufacturer material to verify values before accepting new ranges.
Mission CliniCheck Assayed Chemistry Control, Levels 1 and 2 Predicate Device:
Predicate 510(k): K103364
2
Comparison with Predicate Device:
| Product | New Device | Predicate |
|---|---|---|
| Name | Mission CliniCheck Assayed Chemistry | Same |
| Control | ||
| 510(k) | K124009 | K103364 |
| PN | DD-93001D, DD-93002D | Same |
| Intended Use | For in vitro diagnostic use as an assayed | |
| quality control serum to monitor the precision | ||
| of laboratory testing procedures for the | ||
| following analytes, Acetaminophen, Acid | ||
| Phosphatase (Total), Alanine | ||
| Aminotransferase (ALT/GPT), Albumin, | ||
| Alkaline Phosphatase (ALP), Alpha-1 Anti- | ||
| Trypsin, Alpha Fetoprotein, Alpha | ||
| Hydroxybutyrate Dehydrogenase (α-HBDH), | ||
| Amylase, Apolipoprotein A-1 (APO-A1), | ||
| Aspartate Aminotransferase (AST/GOT), | ||
| Bilirubin (Direct), Bilirubin (Total), C3 | ||
| Complement, C4 Complement, Calcium, | ||
| Carbon Dioxide (CO2), Carcinoembryonic | ||
| Antigen (CEA), Ceruloplasmin, Chloride, | ||
| Cholesterol (Total), HDL-Cholesterol, LDL- | ||
| Cholesterol, Cholinesterase, Creatine Kinase | ||
| (CK), Creatinine, Digoxin, Gamma | ||
| Glutamyltransferase (GGT), Glucose, | ||
| Haptoglobin, Immunoglobulin A (IgA), | ||
| Immunoglobulin G (IgG), Immunoglobulin M | ||
| (IgM), Iron, Iron-Binding Capacity, Total | ||
| (TIBC), Iron Binding Capacity, Unsaturated | ||
| (UIBC), Lactate (Lactic acid), Lactate | ||
| Dehydrogenase (LDH), Lipase, Lithium, | ||
| Magnesium, Phosphorus, Potassium, Protein- | ||
| Total, Salicylate, Sodium, T3 Free, T3 Total, | ||
| T4 Free, T4 Total, Thyroid Stimulating | Not assayed for Acetaminophen, | |
| Alpha-1 Anti-Trypsin, Alpha | ||
| Fetoprotein, Carcinoembryonic | ||
| Antigen, Ceruloplasmin, Digoxin, | ||
| Haptoglobin | ||
| Hormone (TSH), Transferrin, Triglycerides, | ||
| Urea, Urea Nitrogen, and Uric Acid on | ||
| instruments listed in the expected values | ||
| chart. | ||
| Matrix | Serum | Same |
| Form | Lyophilized | Same |
| Levels | Two | Same |
| Storage | 2-8°C | Same |
| Reconstituted | 20 days at -20°C | Same |
| Stability | Same | Same |
| Shelf Life | 24 months | Same |
| Packaging | 12 x 5 mL | Same |
Stability
Tests were conducted to determine stability. Accelerated (high temperature) stress test was done and results support a 2 year shelf life when the controls are stored at 2-8°C. Testing showed that reconstituted Mission CliniCheck Assayed Chemistry Controls are stable for up to 20 days at -20°C. Once thawed, the controls cannot be refrozen and must be discarded. Values are also stable for 7 days when stored at 2-8℃ with the following exception: Acid Phosphatase will be stable for 3 days, AST for 1 day, CK, LDH, T4 free and TSH for 6 days when stored tightly capped at 2-8℃.
3
Conclusion:
Based on the results submitted in this pre market notification CliniCheck Assayed Chemistry Control claims substantial equivalence to the predicate device in Composition, that is Acetaminophen, Acid Phosphatase (Total), Alanine Aminotransferase (ALT/GPT), Albumin, Alkaline Phosphatase (ALP), Alpha-1 Anti-Trypsin, Alpha Fetoprotein, Alpha Hydroxybutyrate Dehydrogenase (α-HBDH), Amylase, Apolipoprotein A-1 (APO-A1), Aspartale Aminotransferase (AST/GOT), Bilirubin (Direct), Bilirubin (Total), C3 Complement, C4 Complement, Calcium, Carbon Dioxide (CO), Carcinoembryonic Antigen (CEA), Ceruloplasmin, Chloride, Cholesterol (Total), HDL-Cholesterol, LDL-Cholesterol, Cholinesterase, Creatine Kinase (CK), Creatinine, Digoxin, Gamma Glutamyltransferase (GGT), Glucose, Haptoglobin, Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Iron, Iron-Binding Capacity, Total (TIBC), Iron Binding Capacity, Unsaturated (UIBC), Lactate (Lactic acid), Lactate Dehydrogenase (LDH), Lipase, Lithium, Magnesium, Phosphorus, Potassium, Protein-Total, Salicylate, Sodium, T3 Free, T3 Total, T4 Free, T4 Total, Thyroid Stimulating Hormone (TSH), Transferrin, Triglycerides, Urea Nitrogen, and Uric Acid, Intended use, Packaging, Storage, and Shelf life
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, a symbol often associated with healthcare, with three horizontal bars representing the staff. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus. The logo is black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 17, 2013
Diamond Diagnostics, Inc. C/O Kathy Cruz 333 Fiske St HOLLISTON MA 01746
Re: K124009
Trade/Device Name: Mission CliniCheck Assayed Chemistry Control Regulation Number: 21 CFR 862.1660 Regulation Name: Quality control material Regulatory Class: I, reserved Product Code: JJY Dated: March 20, 2013 Received: April 04, 2013
Dear Ms. Cruz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be , found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for
5
Page 2-Ms. Cruz
the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDeyices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Carol C. Benson -S for
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K124009
Device Name: Mission CliniCheck Assayed Chemistry Control
Indications for Use:
Mission CliniCheck Controls is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the following analytes: Acetaminophen, Acid Phosphatase (Total), Alanine Aminotransferase (ALT/GPT), Albumin, Alkaline Phosphatase (ALP), Alpha-1 Anti-Trypsin, Alpha Fetoprotein, Alpha Hydroxybutyrate Dehydrogenase (α-HBDH), Amylase, Apolipoprotein A-1 (APO-A1), Aspartate Aminotransferase (AST/GOT), Bilirubin (Direct), Bilirubin (Total), C3 Complement, C4 Complement, Calcium, Carbon Dioxide (CO2), Carcinoembryonic Antigen (CEA), Ceruloplasmin, Chloride, Cholesterol (Total), HDL- Cholesterol, LDL-Cholesterol, Cholinesterase, Creatine Kinase (CK), Creatinine, Digoxin, Gamma Glutamyltransferase (GGT), Glucose, Haptoglobin, Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Iron, Iron-Binding Capacity, Total (TIBC), Iron-Binding Capacity, Unsaturated (UIBC), Lactate (Lactic acid), Lactate Dehydrogenase (LDH), Lipase, Lithium, Magnesium, Phosphorus, Potassium, Protein-Total, Salicylate, Sodium, T3 Free, T3 Total, T4 Free, T4 Total, Thyroid Stimulating Hormone (TSH), Transferrin, Triglycerides, Urea Nitrogen, and Uric Acid on instruments listed in the expected values chart.
Prescription Use
(21 CFR Part 801 Subpart D)
And/Or
Over the Counter Use
(21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Yung W.Chan -S
Division Sign-Off Office of In Vitro Diagnostics and Radiological Health
510(k) K124009